Patents by Inventor Sakari Lamminmaki
Sakari Lamminmaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220133149Abstract: Systems and methods of wireless sensing of physiological data includes obtaining physiological data from a patient with a wireless sensor. A patient location device determines a location of the patient. A location of the wireless sensor is obtained. The physiological data from the wireless sensor is associated to the patient based upon a determined proximity of the location of the wireless sensor to the location of the patient.Type: ApplicationFiled: January 13, 2022Publication date: May 5, 2022Applicant: General Electric CompanyInventors: Magnus Kall, Tuomas Laine, Mika Tapaninaho, Oliver Mayer, Sakari Lamminmaki
-
Patent number: 11246485Abstract: Systems and methods of wireless sensing of physiological data includes obtaining physiological data from a patient with a wireless sensor. A patient location device determines a location of the patient. A location of the wireless sensor is obtained. The physiological data from the wireless sensor is associated to the patient based upon a determined proximity of the location of the wireless sensor to the location of the patient.Type: GrantFiled: December 22, 2016Date of Patent: February 15, 2022Assignee: General Electric CompanyInventors: Magnus Kall, Tuomas Laine, Mika Tapaninaho, Oliver Mayer, Sakari Lamminmaki
-
Patent number: 11076932Abstract: Systems and methods for wireless sensing include a wireless senor which includes a physiological sensor and an identification sensor. The physiological sensor obtains physiological data from a patient and the identification sensor detects a unique characteristic of the patient as identification data. The identification data is used to produce a unique identifier which is transmitted wirelessly from the wireless sensor along with the physiological data to associate the transmitted physiological data to the patient.Type: GrantFiled: November 30, 2016Date of Patent: August 3, 2021Assignee: General Electric CompanyInventors: Magnus Kall, Tuomas Laine, Mika Tapaninaho, Sakari Lamminmaki
-
Patent number: 10993644Abstract: A SpO2 measurement system includes at least one light transmitter configured to transmit a first wavelength light and a second wavelength light into tissue of a patient, wherein the second wavelength is shorter than the first wavelength, and a detection device that detects the first wavelength light and the second wavelength light emitted from the tissue of the patient. The SpO2 measurement system operates the at least one light transmitter in a high power mode during a first time period to determine a SpO2 value and a high power DC ratio based on the first wavelength light and the second wavelength light detected during operation in the high power mode. The SpO2 measurement operates the at least one light transmitter in a low power mode during a second time period to determine a low power DC ratio based on the first wavelength light and the second wavelength light detected during operation in the low power mode, and to determine a blood oxygenation status for the patient based on the low power DC ratio.Type: GrantFiled: December 21, 2018Date of Patent: May 4, 2021Assignee: General Electric CompanyInventors: Matti Veli Tapani Huiku, Sakari Lamminmaki
-
Publication number: 20200196926Abstract: A SpO2 measurement system includes at least one light transmitter configured to transmit a first wavelength light and a second wavelength light into tissue of a patient, wherein the second wavelength is shorter than the first wavelength, and a detection device that detects the first wavelength light and the second wavelength light emitted from the tissue of the patient. The SpO2 measurement system operates the at least one light transmitter in a high power mode during a first time period to determine a SpO2 value and a high power DC ratio based on the first wavelength light and the second wavelength light detected during operation in the high power mode. The SpO2 measurement operates the at least one light transmitter in a low power mode during a second time period to determine a low power DC ratio based on the first wavelength light and the second wavelength light detected during operation in the low power mode, and to determine a blood oxygenation status for the patient based on the low power DC ratio.Type: ApplicationFiled: December 21, 2018Publication date: June 25, 2020Applicant: General Electric CompanyInventors: Matti Veli Tapani Huiku, Sakari Lamminmaki
-
Patent number: 10681562Abstract: According to an aspect, there is provided a network deployment analysis apparatus. It is assumed that information on a wireless communications network of first and second types are maintained in a database. The network deployment analysis apparatus causes performing downlink measurements on reference signals transmitted by one or more access nodes in the wireless communications network of the first type using a plurality of terminal devices in said network. In response to receiving information on results of the downlink measurements, the network deployment analysis apparatus calculates one or more values of traffic absorption capability associated with one or more potential cell deployments in a wireless communications network of the second type based on the received information and the information maintained in the database. The results of the calculating are outputted to a user device for facilitating network planning of the wireless communications network of the second type.Type: GrantFiled: November 15, 2019Date of Patent: June 9, 2020Assignee: NOKIA SOLUTIONS AND NETWORKS OYInventors: Riku Tuomas Ertimo, Jyri Sakari Lamminmäki, Jarkko Kalervo Itkonen
-
Publication number: 20200178085Abstract: According to an aspect, there is provided a network deployment analysis apparatus. It is assumed that information on a wireless communications network of first and second types are maintained in a database. The network deployment analysis apparatus causes performing downlink measurements on reference signals transmitted by one or more access nodes in the wireless communications network of the first type using a plurality of terminal devices in said network. In response to receiving information on results of the downlink measurements, the network deployment analysis apparatus calculates one or more values of traffic absorption capability associated with one or more potential cell deployments in a wireless communications network of the second type based on the received information and the information maintained in the database. The results of the calculating are outputted to a user device for facilitating network planning of the wireless communications network of the second type.Type: ApplicationFiled: November 15, 2019Publication date: June 4, 2020Inventors: Riku Tuomas ERTIMO, Jyri Sakari LAMMINMĂ„KI, Jarkko Kalervo ITKONEN
-
Publication number: 20180177397Abstract: Systems and methods of wireless sensing of physiological data includes obtaining physiological data from a patient with a wireless sensor. A patient location device determines a location of the patient. A location of the wireless sensor is obtained. The physiological data from the wireless sensor is associated to the patient based upon a determined proximity of the location of the wireless sensor to the location of the patient.Type: ApplicationFiled: December 22, 2016Publication date: June 28, 2018Applicant: General Electric CompanyInventors: Magnus Kall, Tuomas Laine, Mika Tapaninaho, Oliver Mayer, Sakari Lamminmaki
-
Publication number: 20180147024Abstract: Systems and methods for wireless sensing include a wireless senor which includes a physiological sensor and an identification sensor. The physiological sensor obtains physiological data from a patient and the identification sensor detects a unique characteristic of the patient as identification data. The identification data is used to produce a unique identifier which is transmitted wirelessly from the wireless sensor along with the physiological data to associate the transmitted physiological data to the patient.Type: ApplicationFiled: November 30, 2016Publication date: May 31, 2018Applicant: General Electric CompanyInventors: Magnus Kall, Tuomas Laine, Mika Tapaninaho, Sakari Lamminmaki